Red cell survival and iron kinetics in kala-azar.
D000606:Amino Sugars / Q000627:therapeutic use; D000740:Anemia / Q000209:etiology / Q000378:metabolism; D000965:Antimony / Q000627:therapeutic use; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D001663:Bilirubin / Q000097:blood; D001810:Blood Volume; D002675:Child, Preschool; D002860:Chromium Radioisotopes; D004905:Erythrocyte Aging; D004906:Erythrocyte Count; D004912:Erythrocytes / Q000378:metabolism*; D006801:Humans; D007223:Infant; D007501:Iron / Q000378:metabolism*; D007504:Iron Radioisotopes; D007700:Kinetics; D007898:Leishmaniasis, Visceral / Q000097:blood* / Q000188:drug therapy / Q000378:metabolism; D010953:Plasma Volume; D011868:Radioisotopes; D012975:Sodium Isotopes; D013012:Sorbitol / Q000627:therapeutic use; D013163:Splenomegaly; D013997:Time Factors
D000606:Amino Sugars; D000981:Antiprotozoal Agents; D002860:Chromium Radioisotopes; D007504:Iron Radioisotopes; D011868:Radioisotopes; D012975:Sodium Isotopes; D013012:Sorbitol; D000965:Antimony; D007501:Iron; D001663:Bilirubin